ASRT

Assertio Holdings Inc

Add to Watchlist

Advanced Chart

0.888

+0.002(0.226%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

0.900

Open

0.8819

VWAP

0.89

Vol

109.58K

Mkt Cap

85.46M

Low

0.8788

Amount

97.47K

EV/EBITDA(TTM)

Total Shares

95.12M

25.73M

EV/OCF(TTM)

1.42

P/S(TTM)

0.72

Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through the acquisition or licensing of approved products. Its commercial capabilities include marketing through both a sales force and an omni-channel promotion model, market access through payor contracting, and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, and CAMBIA (diclofenac potassium for oral solution). INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID). Otrexup is a once weekly single-dose auto-injector containing methotrexate.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

27.43M

+3.56%

-0.050

-64.29%

28.36M

-11.87%

-0.065

-40.91%

27.02M

-7.48%

-0.085

+183.33%

Estimates Revision

The market is revising Downward the revenue expectations for Assertio Holdings, Inc. (ASRT) for FY2025, with the revenue forecasts being adjusted by -2.51% over the past three months. During the same period, the stock price has changed by 28.98%.

Revenue Estimates for FY2025

Revise Downward

-2.51%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+30.28%

In Past 3 Month

Stock Price

Go Up

+28.98%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast ASRT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASRT is 3.00 USD with a low forecast of 3.00 USD and a high forecast of 3.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.888

Low

3.00

Averages

3.00

High

3.00

Current: 0.888

Low

3.00

Averages

3.00

High

3.00

H.C. Wainwright

Buy

downgrade

2025-08-12

Reason

H.C. Wainwright

Price Target

2025-08-12

downgrade

Buy

Reason

H.C. Wainwright lowered the firm's price target on Assertio to $3 from $3.50 and keeps a Buy rating on the shares. The company reported a sales beat and earnings miss, the analyst tells investors in a research note.

Alliance Global Partners

Buy

maintain

2025-05-13

Reason

Alliance Global Partners

Price Target

2025-05-13

maintain

Buy

Reason

Alliance Global Partners lowered the firm's price target on Assertio to $1.50 from $1.75 and keeps a Buy rating on the shares following the Q1 report. The company's Q1 revenue was below forecast driven largely by Rolvedon, the analyst tells investors in a research note. Now that Assertio appears to have cleaned up the opioid overhang litigation, the share price should start tracking Rolvedon, for better or worse, contends Alliance Global .

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Maintains

$4 → $3.5

2025-03-19

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$4 → $3.5

2025-03-19

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

2024-12-16

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

2024-12-16

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

2024-11-25

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

2024-11-25

Reiterates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Assertio Holdings Inc (ASRT.O) is -3.62, compared to its 5-year average forward P/E of 7.45. For a more detailed relative valuation and DCF analysis to assess Assertio Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

7.45

Current PE

-3.62

Overvalued PE

92.33

Undervalued PE

-77.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

2.58

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

3.96

Undervalued EV/EBITDA

1.20

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.94

Current PS

0.00

Overvalued PS

1.37

Undervalued PS

0.51

Financials

Annual

Quarterly

FY2025Q2

YoY :

-6.12%

29.22M

Total Revenue

FY2025Q2

YoY :

+122.15%

-8.04M

Operating Profit

FY2025Q2

YoY :

+345.07%

-16.35M

Net Income after Tax

FY2025Q2

YoY :

+325.00%

-0.17

EPS - Diluted

FY2025Q2

YoY :

+158.44%

19.09M

Free Cash Flow

FY2025Q2

YoY :

-36.27%

31.87

Gross Profit Margin - %

FY2025Q2

YoY :

-11.12%

15.43

FCF Margin - %

FY2025Q2

YoY :

+374.24%

-55.96

Net Margin - %

FY2025Q2

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

70.0K

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

70.0K

USD

Months

ASRT News & Events

Events Timeline

2025-09-15 (ET)

2025-09-15

09:09:26

Assertio Reveals New Findings from SYMPAZAN Oral Film Study

2024-12-17 (ET)

2024-12-17

07:34:13

Assertio Holdings appoints Mark Reisenauer to board of directors

2024-12-13 (ET)

2024-12-13

07:03:44

Assertio Holdings announces results of Rolvedon injection study

News

7.0

09-21Globenewswire

Investor Alert: 3-Day Deadline in Securities Lawsuit Involving Spectrum Pharmaceuticals (SPPI) and Assertio Holdings (ASRT) – Hagens Berman

7.0

09-18Globenewswire

URGENT: Berger Montague Urges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors to Reach Out Before September 24, 2025

9.0

09-15Newsfilter

Assertio Unveils Groundbreaking Real-World Study on Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

People Also Watch

CAPN

Cayson Acquisition Corp

Auburn National Bancorporation Inc

Alphatime Acquisition Corp

Pathfinder Bancorp Inc (MARYLAND)

15.500

USD

+0.78%

FAQ

What is Assertio Holdings Inc (ASRT) stock price today?

The current price of ASRT is 0.888 USD — it has increased 0.23 % in the last trading day.

ASRT

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

ASRT News & Events

Events Timeline

News

People Also Watch

FAQ

What is Assertio Holdings Inc (ASRT) stock price today?

What is Assertio Holdings Inc (ASRT)'s business?

What is the price predicton of ASRT Stock?

What is Assertio Holdings Inc (ASRT)'s revenue for the last quarter?

What is Assertio Holdings Inc (ASRT)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Assertio Holdings Inc (ASRT)'s fundamentals?

How many employees does Assertio Holdings Inc (ASRT). have?

What is Assertio Holdings Inc (ASRT) market cap?